Evidence map›Paper›PMID 27406559›Full record

ArticlemBio2016

Salmonella Effectors SseF and SseG Interact with Mammalian Protein ACBD3 (GCP60) To Anchor Salmonella-Containing Vacuoles at the Golgi Network.

Xiu-Jun Yu, Mei Liu, David W Holden

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. The Manipulation of Host Cells byInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Molecular strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. The interplay betweenCell insight · 2025
    Review
  12. International journal of molecular sciences · 2025
    Review
  13. Roles of SPI-2 T3SS effectors in virulence ofFrontiers in veterinary science · 2025
    Article
  14. Infection biology ofEcoSal Plus · 2024
    Review
  15. Article
  16. TheMicrobiology (Reading, England) · 2023
    Article
  17. mBio · 2023
    Article
  18. FromACS omega · 2023
    Review
  19. Speaking the host language: howMicrobiology (Reading, England) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiu-Jun YuMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Mei LiuMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
David W HoldenMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom d.holden@imperial.ac.uk.
Imperial College London · GB

Funding

Medical Research Council MR/J006874/1Wellcome Trust
6 · The paper itself

Abstract

unlabelledFollowing infection of mammalian cells, Salmonella enterica serovar Typhimurium (S Typhimurium) replicates within membrane-bound compartments known as Salmonella-containing vacuoles (SCVs). The Salmonella pathogenicity island 2 type III secretion system (SPI-2 T3SS) translocates approximately 30 different effectors across the vacuolar membrane. SseF and SseG are two such effectors that are required for SCVs to localize close to the Golgi network in infected epithelial cells. In a yeast two-hybrid assay, SseG and an N-terminal variant of SseF interacted directly with mammalian ACBD3, a multifunctional cytosolic Golgi network-associated protein. Knockdown of ACBD3 by small interfering RNA (siRNA) reduced epithelial cell Golgi network association of wild-type bacteria, phenocopying the effect of null mutations of sseG or sseF Binding of SseF to ACBD3 in infected cells required the presence of SseG. A single-amino-acid mutant of SseG and a double-amino-acid mutant of SseF were obtained that did not interact with ACBD3 in Saccharomyces cerevisiae When either of these was produced together with the corresponding wild-type effector by Salmonella in infected cells, they enabled SCV-Golgi network association and interacted with ACBD3. However, these properties were lost and bacteria displayed an intracellular replication defect when cells were infected with Salmonella carrying both mutant genes. Knockdown of ACBD3 resulted in a replication defect of wild-type bacteria but did not further attenuate the growth defect of a ΔsseFG mutant strain. We propose a model in which interaction between SseF and SseG enables both proteins to bind ACBD3, thereby anchoring SCVs at the Golgi network and facilitating bacterial replication. IMPORTANCE: Upon invasion of epithelial cells, the majority of vacuoles containing Salmonella enterica migrate to the perinuclear region-located Golgi network and remain in this region of the cell during the first few rounds of bacterial replication, forming a clustered microcolony of vacuoles. This process requires the action of SseF and SseG, two effector proteins that are translocated by the Salmonella SPI-2 type III secretion system. However, little is known about how they function. Here, we show that both proteins interact with the mammalian Golgi network-associated protein ACBD3. To our knowledge, the SseF-SseG-ACBD3 interaction is the first example of a tethering complex between a pathogen-containing vacuole and a host cell organelle.

Indexed as

Host-Pathogen InteractionsAdaptor Proteins, Signal TransducingBacterial ProteinsDNA Mutational AnalysisEpithelial CellsGene Knockdown TechniquesMembrane ProteinsMutant ProteinsProtein BindingProtein Interaction MappingSalmonella typhimuriumTwo-Hybrid System TechniquesVacuolesACBD3 protein, humanAdaptor Proteins, Signal TransducingBacterial ProteinsMembrane ProteinsMutant Proteins

Identifiers

PMID27406559
PMCPMC4958240
OpenAlexW2465055674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.